INTS vs SOFI
Intensity Therapeutics, Inc. Common stock (INTS) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
INTS currently screens at market cap $7.7M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the INTS and SOFI stock pages for the full models.
Not investment advice.